Bioventus Names Robert Claypoole as President and Chief Executive Officer
DURHAM, N.C., Dec. 19, 2023 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq:BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that its Board of Directors has appointed Robert (Rob) Claypoole as Bioventus’ President and Chief Executive Officer and a member of its Board of Directors, effective January 10, 2024. Mr. Claypoole succeeds Mr. Anthony Bihl who has served as interim CEO and a director on the Board since April 2023.
Related news for (BVS)
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/06/25 06:00 PM
- MoBot’s Stock Market Highlights – 08/06/25 05:00 PM
- Don’t Miss Out: MoBot’s Latest Stock Updates 08/06/25 04:00 PM
- 24/7 Market News Snapshot 06 August, 2025 – Bioventus Inc. Class A Common Stock (NASDAQ:BVS)
- Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity